Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities

Vaccine

Volumn 29, Issue 50, 2011, Pages 9316-9320

  Tohme, Rania A ^a   Awosika Olumo, Debo ^b   Nielsen, Carrie ^a   Khuwaja, Salma ^b   Scott, Jennifer ^b   Xing, Jian ^a   Drobeniuc, Jan ^a   Hu, Dale J ^a   Turner, Cynthia ^b   Wafeeg, Toni ^b   Sharapov, Umid ^a   Spradling, Philip R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Houston Department of Health and Human Services   (United States)

Author keywords

Hepatitis B vaccine; Immunity; Older adults; Outbreaks; Seroprotection

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC PATIENT; EPIDEMIC; EVALUATION; FEMALE; HEALTH CARE FACILITY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINATION;

AGED; AGED, 80 AND OVER; ASSISTED LIVING FACILITIES; DISEASE OUTBREAKS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; VACCINES, SYNTHETIC;

EID: 80855144202     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.011     Document Type: Article

References (17)

1. Wasley A., Kruszon-Moran D., Kuhnert W., Simard E., Finelli L., McQuillan G., Bell B.. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010, 202:192-201.
2. CDC A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP). Part II: immunization of adults. MMWR 2006, 55(RR-16):1-33.
3. Counard C.A., Perz J.F., Linchangco P.C., Christiansen D., Ganova-Raeva L., Xia G., et al. Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc 2010, 58:306-311.
4. Centers for Disease Control and Prevention Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices-Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep 1997, 46:217-221.
5. Centers for Disease Control Prevention Transmission of hepatitis B virus among persons undergoing blood-glucose monitoring in long-term care facilities-Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep 2005, 54:220-223.
6. Thompson N.D., Perz J.F., Moorman A.C., Holmberg S.D. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009, 150:33-39.
7. Patel A.S., White-Comstock M.B., Woolard C.D., Perz J.F. Infection Control practices in assisted living facilities: a response to hepatitis B virus infection outbreaks. Infect Control Hosp Epidemiol 2009, 30:209-214.
8. Centers for Disease Control and Prevention. [accessed 21.06.11]. http://www.cdc.gov/obesity/defining.html.
9. Wolters B., Junge U., Dziuba S., Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine 2003, 21:3623-3628.
10. Van der Wielen M., Van Damme P., Chlibek R., Smetana J., Von Sonnenburg F. Hepatitis A/B vaccination of adults over 40years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006, 24:5509-5515.
11. Rendi-Wagner P., Kundi M., Stemberger H., Wiedermann G., Holzmann H., Hofer M., et al. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001, 19:2055-2060.
12. Stoffel M., Lievens M., Dieussaert I., Martin I., Andre F. Immunogenicity of Twinrix in older adults: a critical analysis. Expert Rev Vaccines 2003, 2(1):9-14.
13. Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwitz E., Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998, 15:1-8.
14. Denis F., Mounier M., Hessel L., Michel J.P., Gualde N., Dubois F., et al. Hepatitis-B vaccination in the elderly. J Infect Dis 1984, 149(6):1019.
15. Höhler T., Groeger-Bicanic G., Hoet B., Stoffel M. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults. Vaccine 2007, 25:1503-1508.
16. Fisman D.N., Agrawal D., Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002, 35:1368-1375.
17. Effros R.B. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2007, 25:599-604.